Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 7689919)

  • 1. Pelvic exenteration for recurrent and extensive primary colorectal adenocarcinoma.
    Yeung RS; Moffat FL; Falk RE
    Cancer; 1993 Sep; 72(6):1853-8. PubMed ID: 7689919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Total pelvic exenteration: effective palliation of perineal pain in patients with locally recurrent prostate cancer.
    Kamat AM; Huang SF; Bermejo CE; Rosser CJ; Pettaway CA; Pisters PW; Guitreau D; Pisters LL
    J Urol; 2003 Nov; 170(5):1868-71. PubMed ID: 14532795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pelvic exenteration for recurrent colorectal carcinoma: a review.
    Yeung RS; Moffat FL; Falk RE
    Cancer Invest; 1994; 12(2):176-88. PubMed ID: 8131093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pelvic exenterative procedures for locally advanced or recurrent colorectal carcinoma in a community hospital.
    Vitelli CE; Crenca F; Fortunato L; Di Nardo A; Farina M; Mustacciuoli G
    Tech Coloproctol; 2003 Oct; 7(3):159-63. PubMed ID: 14628159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Total pelvic exenteration for locally advanced colorectal carcinoma.
    Shirouzu K; Isomoto H; Kakegawa T
    Br J Surg; 1996 Jan; 83(1):32-5. PubMed ID: 8653356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pelvic exenteration for recurrent endometrial cancer.
    Barakat RR; Goldman NA; Patel DA; Venkatraman ES; Curtin JP
    Gynecol Oncol; 1999 Oct; 75(1):99-102. PubMed ID: 10502433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contemporary outcomes of total pelvic exenteration in the treatment of colorectal cancer.
    Jimenez RE; Shoup M; Cohen AM; Paty PB; Guillem J; Wong WD
    Dis Colon Rectum; 2003 Dec; 46(12):1619-25. PubMed ID: 14668586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Indications for primary and secondary exenterations in patients with cervical cancer.
    Marnitz S; Köhler C; Müller M; Behrens K; Hasenbein K; Schneider A
    Gynecol Oncol; 2006 Dec; 103(3):1023-30. PubMed ID: 16890276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pelvic Exenteration as Potential Cure and Symptom Relief in Advanced and Recurrent Gynaecological Cancer.
    Soeda S; Furukawa S; Sato T; Ueda M; Kamo N; Endo Y; Kojima M; Nomura S; Kataoka M; Fujita S; Endo H; Takahashi T; Watanabe T; Yamada H; Fujimori K
    Anticancer Res; 2019 Oct; 39(10):5631-5637. PubMed ID: 31570460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pelvic Exenterations for Advanced and Recurrent Endometrial Cancer: Clinical Outcomes of 40 Patients.
    Schmidt AM; Imesch P; Fink D; Egger H
    Int J Gynecol Cancer; 2016 May; 26(4):716-21. PubMed ID: 26937752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retrospective review of pelvic malignancies undergoing total pelvic exenteration.
    Kuhrt MP; Chokshi RJ; Arrese D; Martin EW
    World J Surg Oncol; 2012 Jun; 10():110. PubMed ID: 22703863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Urinary complications of pelvic exenterations for rectal cancer with urinary invasion].
    Gas J; Beauval JB; Chalret du Rieu M; Bou Nasr E; Philis A; Kirzin S; Thoulouzan M; Soulié M; Ghouti L
    Prog Urol; 2015 May; 25(6):348-54. PubMed ID: 25804429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of recurrent adenocarcinoma of the endometrium with pelvic exenteration.
    Morris M; Alvarez RD; Kinney WK; Wilson TO
    Gynecol Oncol; 1996 Feb; 60(2):288-91. PubMed ID: 8631553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pelvic exenteration.
    Lindsey WF; Wood DK; Briele HA; Greager JA; Walker MJ; Bork J; Das Gupta TK
    J Surg Oncol; 1985 Dec; 30(4):231-4. PubMed ID: 2417058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterns of recurrence after pelvic exenteration for colorectal adenocarcinoma.
    Hafner GH; Herrera L; Petrelli NJ
    Arch Surg; 1991 Dec; 126(12):1510-3. PubMed ID: 1842181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Curative pelvic exenteration: initial experience and clinical outcome.
    Ali Uraiqat A; Al Nsour D; Mestareehy KM; Allababdeh MS; Naffa MTF; Alrabee MM; Al-Hammouri F
    Pan Afr Med J; 2023; 44():170. PubMed ID: 37455871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Morbidity and mortality after pelvic exenteration for colorectal adenocarcinoma.
    Hafner GH; Herrera L; Petrelli NJ
    Ann Surg; 1992 Jan; 215(1):63-7. PubMed ID: 1731650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sacral resection with pelvic exenteration for advanced primary and recurrent pelvic cancer: a single-institution experience of 100 sacrectomies.
    Milne T; Solomon MJ; Lee P; Young JM; Stalley P; Harrison JD; Austin KK
    Dis Colon Rectum; 2014 Oct; 57(10):1153-61. PubMed ID: 25203370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome of total pelvic exenteration for locally recurrent rectal cancer.
    Ike H; Shimada H; Ohki S; Yamaguchi S; Ichikawa Y; Fujii S
    Hepatogastroenterology; 2003; 50(51):700-3. PubMed ID: 12828064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes of total pelvic exenteration for colorectal cancer.
    Nishio M; Sakakura C; Nagata T; Miyashita A; Hamada T; Ikoma H; Kubota T; Nakanishi M; Kimura A; Ichikawa D; Kikuchi S; Fujiwara H; Okamoto K; Ochiai T; Kokuba Y; Taniguchi H; Sonoyama T; Hagiwara A; Otsuji E
    Hepatogastroenterology; 2009; 56(96):1637-41. PubMed ID: 20214208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.